← Back to headlines
NRx Pharmaceuticals Reports Q4 Earnings and Call Highlights
NRx Pharmaceuticals announced its Q4 GAAP EPS of -$1.34 and revenue of $1.23 million, with further details highlighted during its earnings call.
24 Mar, 16:37 — 24 Mar, 16:37
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: seeking-alpha · 24 Mar, 11:19|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning


